BioCentury
ARTICLE | Clinical News

MitoQ: Phase II started

May 29, 2006 7:00 AM UTC

Antipodean began a double-blind, placebo-controlled, New Zealand and Australian Phase II trial in 120 treatment-naïve patients to receive 40 or 80 mg/day MitoQ. ...